GlassScriptPhysician profile
Richard Valinotti
NPI 1578605275
$1,422.25
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $374 · 2021: $547 · 2022: $228.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $278.59 | 2021-2022 | |
| Pfizer INC. | $274.48 | 2019-2022 | |
| Novo Nordisk INC | $226.36 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $121.41 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.04 | 2019-2021 | |
| Lilly USA, LLC | $50.15 | 2019-2021 | |
| Amgen INC. | $43.15 | 2019-2020 | |
| Glaxosmithkline, LLC. | $39.73 | 2021 | |
| Janssen Pharmaceuticals, INC | $39.65 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $39.25 | 2019-2021 | |
| Amarin Pharma, INC. | $37.79 | 2020 | |
| Sanofi Pasteur INC. | $28.68 | 2019 | |
| Althera Pharmaceuticals LLC | $21.61 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.21 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $19.90 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.58 | 2020 | |
| Horizon Therapeutics Plc | $18.90 | 2022 | |
| Allergan, INC. | $17.38 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.94 | 2021 | |
| Supernus Pharmaceuticals, INC. | $14.03 | 2021 | |
| Abbott Laboratories | $12.06 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Valinotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.